News

Surgeons Remove Spinal Tumor Through Eye Socket in World-First Operation
New technique preserves major nerves, blood vessels, and other critical structures in a hard-to-access area. In a ...
Warning to pet owners after dog nearly loses an eye due to grass seed injury
A dog owner has issued a warning to all pet owners across the North East after her pet picked up an injury which nearly ...
Senior Dog 'Riddled With Cancer' Taken To Shelter, Woman Knows What To Do
Chrissy Elder happened to be at the shelter when 16-year-old Sammy was about to be surrendered by his owner who had "tears in his eyes." ...
IEEE2d
An Enhanced SVM Model for Eye Cancer Diagnosis Using Image Feature
Eye cancer., also called ocular cancer., affects the eye and its structure. As with other conditions., early detection and correct diagnosis are key to effective treatment; however., this can be ...
CBS Chicago on MSN13d
How canine cancer advances are helping humans too
New advances in cancer research and treatment in dogs is also helping treatment for people, too. Hear Iranian foreign ...
Medindia14d
New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes
The combined therapeutic approach showed improved outcomes and was well-tolerated. In the study, 14 dogs received one dose of carboplatin followed by ECI® initiated 21 days later.
KTLA14d
New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes - KTLA
LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ...
Yahoo Finance15d
New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes - Yahoo Finance
ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS Cancer Immunotherapy (ECI®), a ...